Full article available to subscribers
Readers may be aware of the article published in the April 16-22 2011 edition of the New Zealand Listener covering aspects of the management of dementia, titled "Good morning sweetheart". Whilst the article records many good things, it has reported only half, and a very particular half, of the views I hold on prescribing antipsychotic medications to people with dementia. What was intended as a considered shot across the bows of prescribers reads more like a thermonuclear explosion on the foredeck.I encourage all doctors and health professionals who are fellow-prescribers of these medicines to read the RANZCP's Faculty of Psychiatry of Old Age (NZ) Guidelines on the topic. These can be accessed for free on line at : http://www.bpac.org.nz/a4d/ranzcpGuide.asp and ordered for free in hardcopy form from the PHARMAC website: www.pharmaconline.co.nzThe key messages of this document stand: (1) Prescribe the right medicine at the right time for the right patient, (2) Always prescribe these medicines in tandem with non-pharmacological management for behavioural and psychological symptoms in dementia, and (3) Routinely review these medicines for possible trial withdrawal after 3 months. Matthew Croucher Psychiatrist of Old Age Christchurch, New Zealand
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz